208 related articles for article (PubMed ID: 17656682)
1. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide.
Vilela RM; Lands LC; Meehan B; Kubow S
Int Immunopharmacol; 2006 Nov; 6(11):1651-64. PubMed ID: 16979119
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside.
Garić D; De Sanctis JB; Wojewodka G; Houle D; Cupri S; Abu-Arish A; Hanrahan JW; Hajduch M; Matouk E; Radzioch D
J Mol Med (Berl); 2017 Oct; 95(10):1053-1064. PubMed ID: 28695226
[TBL] [Abstract][Full Text] [Related]
5. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
7. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
8. Fenretinide prevents the development of osteoporosis in Cftr-KO mice.
Saeed Z; Guilbault C; De Sanctis JB; Henri J; Marion D; St-Arnaud R; Radzioch D
J Cyst Fibros; 2008 May; 7(3):222-30. PubMed ID: 17988958
[TBL] [Abstract][Full Text] [Related]
9. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
10. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
11. Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls.
Guilbault C; Novak JP; Martin P; Boghdady ML; Saeed Z; Guiot MC; Hudson TJ; Radzioch D
Physiol Genomics; 2006 Apr; 25(2):179-93. PubMed ID: 16418321
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
13. CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium.
Davies JC; Stern M; Dewar A; Caplen NJ; Munkonge FM; Pitt T; Sorgi F; Huang L; Bush A; Geddes DM; Alton EW
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):657-63. PubMed ID: 9191467
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis.
Gardner AI; Wu Y; Verhaegh R; Liu Y; Wilker B; Soddemann M; Keitsch S; Edwards MJ; Haq IJ; Kamler M; Becker KA; Brodlie M; Gulbins E
J Biol Chem; 2021; 296():100650. PubMed ID: 33839155
[TBL] [Abstract][Full Text] [Related]
15. Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU/tm1HGU) cystic fibrosis mouse.
Dombrowsky H; Clark GT; Rau GA; Bernhard W; Postle AD
Pediatr Res; 2003 Mar; 53(3):447-54. PubMed ID: 12595593
[TBL] [Abstract][Full Text] [Related]
16. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
Grassmé H; Becker KA; Zhang Y; Gulbins E
Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
[TBL] [Abstract][Full Text] [Related]
17. Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load.
Davidson DJ; Webb S; Teague P; Govan JR; Dorin JR
Pathobiology; 2004; 71(3):152-8. PubMed ID: 15051928
[TBL] [Abstract][Full Text] [Related]
18. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa.
Gosselin D; Stevenson MM; Cowley EA; Griesenbach U; Eidelman DH; Boulé M; Tam MF; Kent G; Skamene E; Tsui LC; Radzioch D
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1253-62. PubMed ID: 9563748
[TBL] [Abstract][Full Text] [Related]
19. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
20. Serum zinc concentration in cystic fibrosis patients with CFTR I1234V mutation associated with pancreatic sufficiency.
AbdulWahab A; Abushahin A; Allangawi M; Chandra P; Abdel Rahman MO; Soliman A
Clin Respir J; 2017 May; 11(3):305-310. PubMed ID: 26096753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
